OTC Dropped From E.U.’s Merger Review

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

OTC Dropped From E.U.’s Merger Review

The European Commission is said to be focusing only on the markets for derivatives traded on exchanges, and not the over-the-counter derivatives market, in its antitrust review of the proposed merger of Deutsche Bank and NYSE Euronext.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Related articles

Gift this article